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httpcense.Abstract Introduction: Many practitioners express concern about the adequacy of imaging using
CO2 in the lower extremities, particularly in the distribution of the popliteal artery and below (5).
Published results have varied considerably with respect to the validity of imaging this anatomy.
Objectives: Review our experience with CO2 angiography using CO2 angioset in evaluation and
intervention of below knee arteries.
Patients and methods: Forty patients with lower limb ischemia were divided into two groups. The
1st group has normal kidney function, subjected to angiography with CO2 and water soluble con-
trast media (WSCM) as the reference standard (control). The 2nd group has subjected only to CO2
angiography due to one or more risk factors related to WSCM. CO2 angioset is a dedicated CO2
injection system used in all patients. In the 1st group; imaging ﬁndings on CO2 and WSCM
angiography were compared while in the 2nd group; ﬁndings were compared with the post proce-
dure clinical and color Doppler ﬁndings.rtery; CDS, color Doppler
a; CO2, carbon dioxide; PA,
volume; PTA, posterior tibial
y; TPT, tibioperoneal trunk;
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550 W. Abdulghaffar et al.Results: All arterial lesions detected on CO2 angiography were comparable to those obtained with
WSCM in the control group. In the 2nd group; post procedure clinical and Doppler ﬁndings cor-
related well with angiographic ﬁndings and angioplasty results. CO2 angiography images have
lower resolution compared to WSCM however, they were reliable for accurate diagnosis and to
guide angioplasty.
Conclusion: CO2 angiography using CO2 angioset is considered a reliable alternate to WSCM in
assessment of below knee arteries and provides a reliable roadmap to interventional procedures.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Carbon dioxide is a nontoxic, compressible gas that has been
used as a contrast agent since the early 1900s (1). As a contrast
agent, CO2 does not appear to carry the risks of either contrast
nephropathy or allergic reaction (2). Since its implementation
in the vascular system by Haskins in the 1970s, the use of
CO2 as a contrast agent has been validated in a number of
studies (1). It has been found to be particularly advantageous
in the treatment of renal artery stenosis and the endovascular
management of infra-renal abdominal aortic aneurysms (3,4).
Despite these encouraging results, the adoption of CO2 as a
contrast agent in the evaluation and treatment of lower
extremity arterial disease has not been as pervasive as one
might expect. There seem to be two primary reasons that con-
tribute to this limitation. The use of a gas rather than a liquid
contrast agent changes a number of elements in the process of
angiography that may be unfamiliar to vascular interventional
practitioners. Many practitioners express concern about the
adequacy of imaging using CO2 in the lower extremities, par-
ticularly in the distribution of the popliteal artery and below
(5). Published results have varied considerably with respect
to the validity of imaging this anatomy (6).
2. Aim of study
To present our experience with CO2 angioset in performing
diagnostic and interventional procedures in patients with lower
limb ischemia with special emphasis on below knee arteries.
3. Patients and methods
This prospective study was approved by the institutional re-
view board and informed consent was obtained from all pa-
tients. It included 40 patients done over a period of
8 months (from March through October 2011). All patients
with symptoms and signs of lower limb ischemia were sub-
jected to thorough clinical examination and color Doppler
study. They were 22 males and 18 females, their age ranged
from 45 to 84 years. Patients were divided into two groups,
each group composed of 20 patients. Patients in the 1st group
have normal kidney function, subjected to angiography with
CO2 then each series is repeated with WSCM as the reference
standard (control group). The 2nd group subjected only to
CO2 angiography due to presence of one or more of indica-
tions described below. All studies were done in angiography
suite (Siemens Axiom Artis) using CO2 angioset (OptiMed).
All procedures were done under local anesthesia (LA) except
two patients done under general anesthesia (GA). Before theprocedure; baseline vital signs (e.g., pulse and blood pressure)
were recorded and echocardiographic ﬁndings (e.g., ejection
fraction) were reviewed.
CO2 angiography was indicated in patients with renal insuf-
ﬁciency especially those with borderline kidney function (ser-
um creatinine 1.5–2.5 mg/dL), intolerance to iodinated
WSCM (e.g., history of allergy), to reduce strain caused by
WSCM (e.g., heart failure, low ejection fraction or complex
interventional procedure), and hyperthyroidism.
CO2 angiography passes through four steps: (1) an end-hole
4F or 5F diagnostic catheter or a 5F-6F sheath is advanced
proximal to examined region e.g., PA or lower SFA to examine
leg arteries, (2) preparation of CO2 angioset which is a dedi-
cated CO2 injection system, (3) elevate patient’s leg 15–20 de-
grees either by tilting the table or using a wedge-shaped
cushion, (4) imaging.
CO2 angioset is composed of a gas bottle containing pure
medical CO2 (99.7 vol.% or higher), pressure relief valve, sterile
ﬁlter (optional but recommended to ﬁlter rust particles), 150 cm
gas supply line with connection to the pressure relief valve,
stop-cock with 90 rotary valve for loading and injection proce-
dure, 100 ml syringe adjustable in 20 ml steps and connection
tube to the patient which is 150 cm in length (Fig. 1A–D).
The set is prepared by removing the syringe from package;
the locking plate is set to the desired volume. The gas supply
line is connected to the outlet of pressure relieve valve of the
gas bottle, the system is rinsed by turning the stop-cock back
and forth ﬁve times holding the syringe vertically (CO2 is hea-
vier than air). After rinsing, the stop-cock is set to the loading
position then; the connection tube is linked to the catheter or
sheath hub or to the side limb of a rotating hemostasis valve if
injection occurs with wire in place. The pressure must be set at
1.3 bars to avoid overdosage.
Regarding imaging; CO2 setting is activated which utilizes
special software required to image negative contrast media
and the number of images should be increased to 4–6 per sec-
ond. After starting the DSA series and preparing the mask
images, injection is carried out by turning the stop-cock to
the injection position. The stop-cock is returned to the loading
position after completion. The CO2 angioset is ready for the
next DSA series.
Imaging of leg arteries is usually performed with 40–60 ml
PCV. Generally we start with lower volume (40 ml PCV) and
if acquired images are not satisfactory; the larger volume
(60 ml PCV) is used. To avoid pain during injection, we start
with lower volumes and wait at least 2 min between each series
(longer for patients with pulmonary disease). In case of severe
leg pains, the leg is positioned at lower level and 50–100 mg
pethidine is injected intravenous. Nitroglycerin 100–300 lg is
injected intra-arterial to enhance gas ﬂow and ﬁlling of the dis-
Fig. 1 Component and function of CO2 angioset. (1A) The set is composed of gas bottle containing pure medical CO2 (1), pressure relief
valve (2), sterile ﬁlter (3), gas supply line with connection to the pressure relief valve (4), special stop-cock with 90 rotary valve (5), 100 ml
syringe adjustable in 20 ml steps (6) and connection tube to the patient (7). (1B) Shows the component and functions of pressure relieve
valve. (1C and D) Shows the syringe and plunger adjustable in 20 ml steps.
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and after nitroglycerin injection.
Breaking of contrast column is noted in 16 cases. This was
overcome by using post-processing stacking software.
4. Results
Regarding control group, all arterial lesions detected on CO2
images were compared with that obtained with WSCM. Ste-
notic lesions were assessed regarding degree and length of ste-
nosis and distal run-off was assessed as well. All lesions show
similar ﬁndings on CO2 and WSCM images (Figs. 2 and 3).
Regarding the 2nd group, diagnosis and angioplasty were
based on CO2 images alone. Post-angioplasty clinical and col-
or Doppler ﬁndings correlated well with imaging ﬁndings and
intervention procedure done (Figs. 4–6).
CO2 injection was painless in 10 cases, pain was mild in 15,
moderate but tolerable in 9 cases, severe intolerable in 4 cases
that required administration of IV sedation (pethidine 50–
100 mg). The 2 cases done under GA are excluded from pain
response assessment. Nitrous oxide was not used as an anes-
thetic agent in these 2 cases.5. Discussion
Carbon dioxide has been used as an arterial contrast agent
since 1971. The development of digital subtraction angiogra-
phy and an automated CO2 injector has increased the practica-bility and safety of using CO2 routinely (7). CO2 angiography
is not available in most centers and generally reserved for pa-
tients with history of contrast allergy or renal dysfunction with
creatinine clearance less than 20 mL per minute. The use is
generally limited to arteries below the diaphragm to minimize
the risk of cerebral embolism. DSA equipment is required for
CO2 angiography (8).
CO2 is a colorless and odorless gas, and it cannot be visu-
ally distinguished from air. The incorrect application of tech-
nique may result in air contamination, which may cause
serious complications. CO2 is approximately 20 times more
soluble than oxygen. When injected into a vessel, CO2 bubbles
completely dissolve within 2–3 min. Two to 3 min should
elapse between injections of CO2 to prevent the localized accu-
mulation and trapping of gas bubbles (9).
CO2 is compressible during injection; it expands in the vessel
as it exits the catheter. Clearing the ﬂuid of the catheter by using
3–5 cc of CO2 before injection reduces the explosive delivery.
The explosive delivery is unlikely to cause vascular damage,
but it may contribute to discomfort during the injection (9).
CO2 is lighter than blood plasma; therefore, it ﬂoats above
the blood (buoyancy). When injected into a large vessel such as
the aorta or inferior vena cava, CO2 bubbles ﬂow along the
anterior part of the vessel, with incomplete blood displacement
along the posterior portion (9). The buoyancy is not a problem
when the vessel to be imaged is smaller than 10 mm in diameter
because the gas bubbles tend to displace the blood in greater
than 80% of the lumen. Elevation of the lower extremity to
15–20 in conjunction with the intra-arterial injection of 100–
Fig. 2 Sixty-two YOM heavy smoker, DM, HTN presented with
acute ischemia LT LL. (A) CO2 angiography shows two stenotic
segments in ATA (arrows), fading away of peroneal A and non
opaciﬁed PTA. These ﬁndings correlated well with WSCM
angiography (B).
Fig. 3 Fifty-ﬁve YOM with foot ulcer and normal kidney function.
arteries shows comparable results. (A and B) Focal stenotic segments in
stenotic segment in DPA. (E and F) CO2 angiography after balloon a
552 W. Abdulghaffar et al.200 lg of nitroglycerin enhances gas ﬂow and ﬁlling of the dis-
tal arteries in the lower extremity.
CO2 is approximately 400 times less viscous than iodinated
contrast medium. The low viscosity permits manual gas injec-
tion with small-bore catheters between the catheter and guide
wire, accounts for better ﬁlling of collateral vessels and allows
detecting very narrow channel in segments that have apparent
total occlusion with WCSM (9). Iodinated contrast medium
mixes with blood when injected into a vessel and becomes di-
luted, making it less dense as it travels through collateral ves-
sels. By contrast, CO2 does not mix with blood, and so it does
not become diluted by collateral ﬂow.
CO2 is less dense than WSCM and the overall quality of
CO2 images is slightly less than that obtained with WSCM.
However, CO2 has several advantages when compared with
WSCM. CO2 is a natural byproduct, so it does not cause aller-
gic reaction. CO2 causes no renal or hepatic toxicity. In addi-
tion, unlimited amounts of CO2 may be used for vascular
imaging because the gas is effectively eliminated by means of
respiration. However, the operator should allow sufﬁcient time
for its clearance. A minimum of 2 min is needed for the ﬁrst
CO2 dose to completely dissolve before another dose is in-
jected. CO2 is particularly useful for patients with compro-
mised cardiac and renal function who are undergoing
complex vascular interventions (9).
In the lower extremities, injection can sometimes give the
patient a somewhat shocking feeling that may prompt move-
ment and cause imaging degradation. Generally, patients are
pre-informed about possibility of pain, they are instructed to
keep limb stable and when necessary, limb is strained. Other
helpful tips are to inject smaller volumes and to allow a period
of time (2–3 min) for CO2 clearance between injections. Pethi-
dine 50–100 mg IV and lowering patient’s leg may also help
alleviate pain. In extreme cases in which a patient is likely to
have difﬁculties remaining still during the procedure, general
anesthesia may be an option. Once again, nitrous oxide should
probably be avoided as an anesthetic agent in these cases.
Multiple studies have suggested that imaging with CO2 is
limited with respect to accuracy at the popliteal artery andAngiography with CO2 (A and C) and WSCM (B and D) for leg
ATA (arrows), block arrow indicates catheter tip. (C and D) Focal
ngioplasty shows good results.
Fig. 4 Sixty-four YOF presented with RT CLI, serum creatinine = 1.8 mg/dL. (A and B) Diagnostic CO2 angiography through 5F
vertebral catheter in PA (block arrow) shows severe stenosis of TPT (green arrow), stenosis of proximal ATA (double arrows in A), total
occlusion of distal ATA and all PTA. There is focal stenotic segment in distal peroneal A (arrow in B). DPA is opaciﬁed via anterior
perforating branch. (C and D) Corresponding post-angioplasty for TPT and peroneal A shows good results.
Fig. 5 Sixty-nine YOM with RT CLI and borderline kidney function for whom diagnosis (A, B and C) and intervention (D and E) done
with CO2 only. (A, B and C) Catheter tip indicated by block arrow, sever PA stenosis (arrow in A), TPT stenosis (green arrow in B),
diffuse stenosis of proximal PTA (small arrows in C). The ATA shows alternating segments of stenosis and total occlusion however, there
is reﬁlling of distal ATA and DPA (B and C). (D and E) Post balloon angioplasty shows reconstruction of PA, TPT and PTA. ATA could
not be recanalized.
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using CO2 angioset and DSA dedicated for CO2 imaging are
greatly helpful regarding diagnosis and intervention for leg
and foot arteries. The diagnostic catheter or sheath shouldbe advanced into lower SFA or popliteal artery, use of in-
tra-arterial nitroglycerin and post-processing stacking help
obtaining good quality images down to pedal arteries (Figs. 3
and 5).
Fig. 6 Sixty-eight YOM with RT CLI and borderline kidney function. (A) Pre-procedure assessment with CDS shows absent ﬂow
signals in ATA (arrows), (B) CO2 angiography conﬁrmed ATA occlusion and also shows occlusion of distal TPT, (C) angioplasty with
2.5 mm plain balloon, (D) post procedure CDS proves recanalization of ATA. Whole procedure performed with CO2 only.
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CO2 is a valuable alternative to traditional contrast agents for
evaluating lower extremity arterial disease. The use of a dedi-
cated injection system provides adequate delivery and avoids
overdose and contamination. Although iodinated contrast
agents still demonstrate superior imaging compared to CO2,
particularly in smaller vessels yet, CO2 as a contrast agent pro-
vides good quality imaging required for reliable diagnosis and
intervention in below knee arteries.
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